An Open-Label, Single-Arm, Multicentric, Prospective, Phase IV Study to Evaluate the Safety and Effectiveness of Indacaterol/Mometasone/Glycopyrronium Dry Powder Inhaler (DPI) in the Management of Asthma Patients (OASIS Study). [PDF]
CureusKarmakar S +10 more
europepmc +1 more source
In-silico drug repositioning studies of Candida albicans Nitrogen permease reactivator 1 (Npr1) kinase. [PDF]
Sci RepDas S +12 more
europepmc +1 more source
Medium-Dose Compared With High-Dose Inhaled Corticosteroids in Combination Triple Inhaler Therapy for Asthma: A Systematic Review and Meta-Analysis. [PDF]
CHEST PulmWarhurst S +7 more
europepmc +1 more source
Treatment of bronchial asthma - A simplified overview. [PDF]
Lung IndiaHarvanová G, Duranková S.
europepmc +1 more source
Cardiac disorders associated with compound long-acting bronchodilators for inhalation: a pharmacovigilance analysis of the FDA adverse event reporting system database. [PDF]
Front Cardiovasc MedLan Y, Hu D, Huang S, Xu M, He Q.
europepmc +1 more source
Indacaterol/Glycopyrronium in Clinical Practice: The Italian Experience [PDF]
Respiration, 2018 openaire +2 more sources
Indacaterol in chronic obstructive pulmonary disease: an update for clinicians
Bronchodilation is the cornerstone of chronic obstructive pulmonary disease (COPD) management and is based on regular treatment with one or more long-acting beta(2) agonists (LABAs).
Yorgancioglu, A
core
Recurarization in the Post-anesthesia Care Unit One Hour After Sugammadex Administration: A Case Report. [PDF]
CureusFelix F +4 more
europepmc +1 more source
Pathophysiology, clinical manifestation, and treatment of tuberculosis-associated chronic obstructive pulmonary disease: a narrative review. [PDF]
Ewha Med JChoi JY.
europepmc +1 more source